Clinical Trials Browser

Phase 1 × INDUSTRY × GSK2110183 × Clear all

NCT01428492 2018-08-08

PKB115125

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT01476137 2017-11-13

A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers

Phase 1 Completed

Multiple Myeloma, Neoplasms